VivoSeq
Other

Drug Metabolism

0

Pipeline Programs

2

Active Trials

1

Companies Involved

Drug Metabolism is an early-stage landscape with 0 programs across 1 company. The most active players are Emalex Biosciences Inc..

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

89/100

Attrition Rate

8/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

12

clinical trials

Completed8 · 67%
Active, not recruiting2 · 17%
Unknown status1 · 8%
Withdrawn1 · 8%

Trial Activity

12 trials

rhGH Therapy on Hepatic Drug Metabolism
Completed·UUniversity of Louisville·N/A·NCT00458991·9 enrolled
Drug Metabolism and Antidepressant
Unknown status·UUniversity Hospital, Geneva·N/A·NCT02438072·100 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)